Trials / Completed
CompletedNCT02840422
Assessment of Patients Quality of Life Treated With Three ARTHRUM H 2% Joint Injections
Assessment of Patients Quality of Life Suffering From Knee Osteoarthritis Treated With Three Intra-articular Injections of ARTHRUM H 2% Over a Period of Six Months
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 138 (actual)
- Sponsor
- LCA Pharmaceutical · Industry
- Sex
- All
- Age
- 40 Years
- Healthy volunteers
- Not accepted
Summary
The reduction of functional limits and disablilities induced by knee osteoarthritis as well as improvement of patients quality of life is a public health need registered amongst the priorities established by the French law of August 9th 2004 relative to Public Health policy. However, the response to this need is not limited to treatment with health products. This clinical trial in real life on ARTHRUM H 2% device aims to analyse patients quality of life treated by intraarticular injections, eventually for several years, by difference of usual clinical trials. This open, prospective, multicentric study aims to analyse, in patient care, the impact of three intraarticular injections of ARTHRUM H 2% on quality of life over a period of 6 months (D180) in the symptomatic treatment of knee osteoarthritis.
Detailed description
Parameters used to determine treatment outcomes include: "Short-Form 12 Health Survey" (SF-12), Pain score of the Western Ontario McMaster Universities Osteoarthritis Index (WOMAC A)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | ARTHRUM H 2% | ARTHRUM H 2% |
Timeline
- Start date
- 2016-02-03
- Primary completion
- 2016-12-08
- Completion
- 2017-07-28
- First posted
- 2016-07-21
- Last updated
- 2024-01-19
Source: ClinicalTrials.gov record NCT02840422. Inclusion in this directory is not an endorsement.